SCHEMBL4606419

SCHEMBL4606419

COc1ccc(C2CC(C(O)=S)=NN2c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.50
CNR2 P34972 5/20 0.50
DRD2 P14416 1/20 0.44
DRD4 P21917 1/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
EGFR P00533 7/20 0.44
L3MBTL1 Q9Y468 3/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
PHGDH O43175 1/20 0.43
KDR P35968 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
BRAF P15056 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4605360 0.90 CNR1 (0.59) CNR1CNR2EGFR
SCHEMBL2019937 0.89 CNR1 (0.55) CNR1CNR2DRD2DRD4MEN1
Hydrochloric Acid SCHEMBL2024424 0.88 CNR1 (0.54) CNR1CNR2DRD2DRD4MEN1
SCHEMBL2024421 0.87 CNR1 (0.55) CNR1CNR2DRD2DRD4MEN1
SCHEMBL4606979 0.86 CNR1 (0.53) CNR1CNR2EGFR
SCHEMBL2991729 0.86 CNR1 (0.54) CNR1CNR2DRD2DRD4MEN1
SCHEMBL4607305 0.86 CNR1 (0.54) CNR1CNR2DRD2DRD4MEN1
SCHEMBL2018083 0.86 CNR1 (0.56) CNR1CNR2DRD2DRD4MEN1
SCHEMBL4606766 0.85 CNR1 (0.53) CNR1CNR2MEN1KMT2AEGFR
SCHEMBL4607107 0.85 CNR1 (0.53) CNR1CNR2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP claimed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP claimed
WO-2007009688-A1 THIOCARBONYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS CB1 MODULATORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-25 WO claimed
EP-1743887-A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP claimed
EP-1946777-A1 Substituted pyrazoline for preventing weight gain Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
EP-1946778-A1 Active substance combination for the treatment of diabetes Laboratorios del Dr. Esteve S.A. (ES) 2008-07-23 EP disclosed
WO-2007009688-A1 THIOCARBONYL-SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS CB1 MODULATORS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-25 WO disclosed
EP-1743887-A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-01-17 EP disclosed